Review: Genetic diversity of plasmodium falciparum: Asexual stages

Tropical Medicine and International Health

Volumn 7, Issue 5, 2002, Pages 395-408

  Meyer, Christian G ^a   May, Jürgen ^a   Arez, Ana Paula ^a   Gil, Jose Pedro ^b   Do Rosario, Virgilio ^c  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Drug resistance; Malaria; Plasmodium falciparum; Polymorphism

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; CHLOROQUINE; CYCLOGUANIL; DAPSONE; MEFLOQUINE; PYRIMETHAMINE; QUINOLINE DERIVATIVE; SULFADOXINE; PROTOZOAL VACCINE;

DRUG RESISTANCE; GENETIC VARIATION; MALARIA;

DATA BASE; DNA SEQUENCE; ESCHERICHIA COLI; GENETIC VARIABILITY; GENOME; HUMAN; MALARIA FALCIPARUM; NONHUMAN; PATHOGENESIS; PLASMODIUM FALCIPARUM; REVIEW; ANIMAL; GENETIC CODE; GENETICS; IMMUNOLOGY; UNITED KINGDOM; UNITED STATES;

ESCHERICHIA COLI; PLASMODIUM FALCIPARUM; PROTOZOA;

ANIMALS; GENETIC CODE; GREAT BRITAIN; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN VACCINES; UNITED STATES; VARIATION (GENETICS);

EID: 0036099608     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2002.00875.x     Document Type: Review

References (138)

1. Allele-specific, nested, one tube PCR: Application to Pfmdr1 polymorphisms in Plasmodium falciparum
2. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples
3. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum
4. Complex mutations in a high proportion of microsatellite loci from the protozoan parasite Plasmodium falciparum
5. Polymorphic microsatellite markers identified in individual Plasmodium falciparum oocysts from wild-caught Anopheles mosquitoes
6. Digital codes from hypervariable tandemly repeated DNA sequences in the Plasmodium falciparum circumsporozoite gene can genetically barcode isolates
7. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells
8. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1
9. Selection for high-level chloroquine resistance results in deam-plification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum
10. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes
11. Molecular epidemiology of malaria in Yaounde, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr1) gene of Plasmodium falciparum
12. Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde, Cameroon
13. Mixed infections with Plasmodium falciparum and P. malariae and fever in malaria
14. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle
15. The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum
16. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: Dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine
17. Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy
18. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria
19. Cross-species immunity in malaria
20. Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum
21. Enzyme variation in Plasmodium falciparum in the Gambia
22. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum
23. A principal target of human immunity to malaria identified by molecular genetic and immunological analyses
24. Extreme geographical fixation of variation in the Plasmodium falciparum gamete surface protein gene Pfs48/45 compared with microsat-ellite loci
25. Selection of a novel K76N mutation in the digestive vacuolar protein PFCRT by non-stepwise chloroquine pressure and recovery of a chloroquine-resistant line from the Plasmodium falciparum 106-1 clone
26. Chromosome size polymorphisms in Plasmodium falciparum can involve deletions and are frequent in natural parasite populations
27. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
28. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine
29. Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates
30. Genetic diversity of Plasmodium falciparum shows geographical variation
31. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections
32. Cerebral sequestration of murine malaria parasites after receptor amplification in mixed infections
33. In vivo chloroquine responses and pfcrt polymorphisms in Bandiagara, Mali
34. A molecular marker for chloroquine-resistant falciparum malaria
35. Previously identified polymorphisms in pfcrt and pfmdr-1 are not predictive of vivo chloroquine response in Kampala, Uganda
36. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr1 genes and clinical response to chloroquine in Kampala, Uganda
37. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin
38. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum
39. Plasmodium falciparum: Detection of antifolate resistance by mutation-specific restriction enzyme digestion
40. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum
41. Molecular cloning and characterization of a putative glutathione reductase gene, the PfGR2 gene, from Plasmodium falciparum
42. Genotyping of Plasmodium falciparum infections by PCR: A comparative multicentre study
43. Plasmodium falciparum: Extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea
44. Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum
45. Microsatellite markers and genetic mapping in Plasmodium falciparum
46. Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses
47. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
48. Correlation of vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda
49. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
50. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum
51. Rapid detection of pfmdr1 mutations in chloroquine-resistant Plasmodium falciparum malaria by polymerase chain reaction analysis of blood spots
52. Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum
53. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl) cyclo-hexyl]-3-hydroxy-1, 4-naphthoquinone (566C80)
54. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum
55. Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7
56. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action
57. Probable resistance to parenteral artemether in Plasmodium falciparum: Case reports from Mumbai (Bombay), India
58. Plasmodium falciparum: A simple, rapid method for detecting parasite clones in microtiter plates
59. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea
60. Plasmodium falciparum: In vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon
61. Variations in the C-terminal repeats of the knob-associated histidine-rich protein of Plasmodium falciparum
62. Specificity of the protective antibody response to apical membrane antigen 1
63. Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3
64. Pyrimethamine resistant Plasmodium falciparum: Overproduction of dihydrofolate reductase by a gene duplication
65. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: Correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes
66. Allelic forms of the knob associated histidine-rich protein gene of Plasmodium falciparum
67. Antigenic diversity and variation in blood stages of Plasmodium falciparum
68. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya
69. Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: High prevalence of a third polymorphic form detected in strains derived from malaria patients
70. Plasmodium falciparum: Isolation of large numbers of parasite clones from infected blood samples
71. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
72. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum
73. Rifins: A second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum
74. Antigenic variation at the infected red cell surface in malaria
75. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria
76. Plasmodium falciparum: Amplification and overexpression of pfmdr1 is not necessary for increased mefloquine resistance
77. Malarone (atovaquone and proguanil hydrochloride): A review of its clinical development for treatment of malaria
78. The epidemiology of severe malaria in an area of low transmission in Thailand
79. Antimalarial drug development and new targets
80. The interaction between Plasmodium falciparum and P. vivax. children on Espiritu Santo island, Vanuatu
81. The sequence of clag 9, a subtelomeric gene of Plasmodium falciparum is highly conserved
82. Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum
83. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil
84. HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families
85. Impact of subpatent multi-species and multi-clonal plasmodial infections on anaemia in children from Nigeria
86. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique
87. Chloroquine-resistant isolates of Plasmodium falciparum with alternative CG2 omega repeat length polymorphisms
88. Pre-erythrocytic malaria vaccine: Mechanisms of protective immunity and human vaccine trials
89. High prevalence of human antibodies to recombinant Duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in nonimmune children
90. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A
91. Comparative analysis of Plasmodium reichenowi and P. falciparum erythrocyte-binding proteins reveals selection to maintain polymorphism in the erythrocyte-binding region of EBA-175
92. Proguanil resistance in Plasmodium falciparum African isolates: Assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing
93. Spread of chloroquine resistance in Plasmodium falciparum
94. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon
95. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria
96. Plasmodium falciparum malaria in Laos: Chloroquine treatment outcome and predictive value of molecular markers
97. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa
98. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydro-pteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance
99. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria
100. Risk factors for gametocyte carriage in uncomplicated falciparum malaria
101. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
102. Population structure and recent evolution of Plasmodium falciparum
103. Plasmodium falciparum antigenic diversity: Evidence of a clonal population structure
104. Interactions between malaria parasites infecting the same vertebrate host
105. Rapid switching to multiple antigenic and adhesive phenotypes in malaria
106. Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan
107. A YAC contig map of Plasmodium falciparum chromosome 4: Characterization of a DNA amplification between two recently separated isolates
108. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum
109. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes
110. Assessment of parasite population dynamics in mixed infections of rodent plasmodia
111. The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea-Bissau
112. Glutathione-S-transferase activity in malarial parasites
113. The large diverse gene family var encodes proteins involved in cytoad-herence and antigenic variation of Plasmodium falciparum-infected erythrocytes
114. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa
115. Plasmodium falciparum: Parasite typing by using a multicopy microsatellite marker, PfRRM
116. A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum
117. Toward a high-resolution Plasmodium falciparum linkage map: Polymorphic markers from hundreds of simple sequence repeats
118. Plasmodium falciparum: A rapid DNA fingerprinting method using microsatellite sequences within var clusters
119. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum
120. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum
121. Var gene diversity in Plasmodium falciparum is generated by frequent recombination events
122. Plasmodium falciparum: Gene mutations and amplification of DHFR genes in parasites grown in vitro in presence of pyrimethamine
123. Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela
124. Recent origin of Plasmodium falciparum from a single progenitor
125. An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross
126. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
127. Genetic analysis of the human malaria parasite Plasmodium falciparum
128. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum
129. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization
130. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy
131. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross
132. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7
133. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum
134. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine
135. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: Assessment of the NOS2A gene and predisposition to infectious disease
136. High prevalence of Plasmodium malariae and Plasmodium ovale in malaria patients along the Thai-Myanmar border, as revealed by acridine orange staining and PCR-based diagnoses
137. Plasmodium falciparum: Mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient